DrugPatentWatch Database Preview
Profile for Australia Patent: 2006223226
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Australia Patent: 2006223226
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Feb 5, 2029 | Pf Prism Cv | TYGACIL | tigecycline |
Start Trial | Oct 24, 2028 | Pf Prism Cv | TYGACIL | tigecycline |
Start Trial | Mar 13, 2026 | Pf Prism Cv | TYGACIL | tigecycline |
Start Trial | Mar 13, 2026 | Pf Prism Cv | TYGACIL | tigecycline |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |